openPR Logo
Press release

Autotransfusion Devices Market Projection By Top Key Players – Haemonetics Corporation, LivaNova PLC, Medtronic, Fresenius SE & Co. KGaA, BD Market Research Forecast 2028

02-04-2022 07:36 AM CET | Health & Medicine

Press release from: Fortune Business Insights™ Pvt. Ltd.

Autotransfusion Devices Market

Autotransfusion Devices Market

Market Overview:

The global autotransfusion devices market is set to gain traction from the increasing adoption of cell salvage as it is capable of lowering the requirement of allogeneic blood transfusion. This will also reduce the risk of adverse complications. This information is given by Fortune Business Insights™ in a new report, titled, “Autotransfusion Devices Market Size, Share & Industry Analysis, By Product Type (Autotransfusion Systems and Consumables & Accessories) By Application (Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, Obstetrics & Gynecological Surgeries, and Others) By End User (Hospitals and Specialty Clinics & Others) and Regional Forecast, 2020-2027.” The report further states that the autotransfusion devices market size was USD 256.7 million in 2019 and is projected to reach USD 307.2 million by 2027, exhibiting a CAGR of 4.1% during the forecast period.

Request for Sample Report PDF @

COVID-19 Pandemic to Affect Growth Stoked by Reduced Surgical Procedures

The COVID-19 pandemic is set to impact growth negatively by declining the number of surgical procedures. The Minneapolis Heart Institute Foundation, for instance, mentioned that during the first quarter of 2020, in the U.S., there was an approximate drop of 40% in the number of STEMI procedures. But, in the 3rd and 4th quarters, the number of surgeries that are to be performed would grow in hospitals worldwide. It would slowly boost growth.

To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit:

How Did We Create This Report?

We gathered information from various studies published by authentic organizations, such as the World Health Organization, National Health Service, Centers for Disease Control and Prevention, American College of Radiology, and Eurostat. At the same time, we conducted exclusive interviews with key stakeholders, such as sales managers, marketing managers, distributors, product managers, and research institutes.

Drivers & Restraints-

Rising Shift towards Intraoperative & Postoperative Cell Salvage to Propel Growth

Nowadays people are rapidly shifting towards intraoperative & postoperative cell salvage to avoid major complications related to allogeneic transfusions. Also, the rising number of high-bleeding surgeries worldwide is set to accelerate the autotransfusion devices market growth in the near future. However, the high demand for minimally invasive surgeries globally because of their cost-effectiveness and ability to provide superior patient comfort may obstruct the demand for autotransfusion devices.


Cardiovascular Surgeries Segment to Dominate Fueled by Increasing Number of Procedures

Based on application, the cardiovascular surgeries segment earned 56.5% in terms of the autologous blood transfusion devices market share in 2019. It is expected to dominate the market throughout the forthcoming years backed by the increasing adoption of autotransfusion devices during such procedures. Besides, the rising number of cardiovascular procedures such as heart transplantations, cardioverter-defibrillator (ICD) and pacemaker implantations, valve replacement surgeries, and coronary artery bypass grafting (CABG) would drive growth.

Regional Analysis-

Development of Healthcare Infrastructure to Favor Growth in Asia Pacific

Geographically, in 2019, North America stood at USD 127.9 million in terms of revenue. The increasing usage of autotransfusion devices in orthopedic and cardiovascular surgeries is anticipated to aid growth in this region. Europe, on the other hand, is set to grow significantly stoked by the strong emphasis on the adoption of intraoperative and postoperative cell salvage techniques. In Asia Pacific, development of the healthcare infrastructure in emerging countries, such as India and China would bolster growth.

Competitive Landscape-

Key Players Focus on Receiving FDA Approval to Gain a Competitive Edge

The market for autotransfusion devices is consolidated with the presence of a very limited number of companies. Haemonetics Corporation and Fresenius SE & Co. KGaA are considered to be major manufacturers. Some of the others are trying to gain a competitive edge by launching new autologous blood transfusion devices and by bagging FDA approvals. Below are the two latest industry developments:

June 2020: ProCell Surgical Inc. unveiled its proprietary medical device called ProCell to automate the outdated and manual activity for intraoperative autotransfusion (IAT) of surgical sponge-blood recovery.
July 2018: Medtronic bagged the FDA approval for its advanced autoLog IQ Autotransfusion System. It is an adaptable and easy autotransfusion system that is capable of providing high-quality blood products automatically.
Ask for Customization @

A list of all the renowned autotransfusion devices manufacturers operating in the market:

Haemonetics Corporation (Massachusetts, U.S.)
LivaNova PLC (London, UK)
Medtronic (Dublin, Ireland)
Fresenius SE & Co. KGaA (Bad Homburg, Germany)
BD (Becton, Dickinson and Company) (Franklin Lakes, U.S.)
Beijing Jingjing Medical Equipment Co., Ltd. (Beijing, China)
Related Article @

NOTE: Our team is studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. We aim to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Autotransfusion Devices Market Projection By Top Key Players – Haemonetics Corporation, LivaNova PLC, Medtronic, Fresenius SE & Co. KGaA, BD Market Research Forecast 2028 here

News-ID: 2544897 • Views: 213

More Releases from Fortune Business Insights™ Pvt. Ltd.

Global Dermatophytic Onychomycosis Treatment Market Size Covered By Global Analy …
Market Overview The global dermatophytic onychomycosis treatment market size is predicted to reach USD 6.63 billion by 2028, exhibiting a CAGR of 7.4% during the forecast period. The rising prevalence of diabetes and incidences of chronic nail fungus infection will lead to heavy demand for dermatophytic onychomycosis treatment, which, in turn, will foster the growth of the market, it is mentioned in a report, titled "Dermatophytic Onychomycosis Treatment Market Size, Share
Global Wound Care Market Size Covered By Global Analysis, Share, Segment, Type, …
Market Overview A comprehensive analysis of the various factors and parameters is carried out to present the report on the global Wound Care Market. The marker concentration in the global market as well as the revenue that is earned from the different market segments that comprise the Wound Care Market have been identified and are evaluated in the report. The market status from the year 2022 to the year 2028 that
Telerehabilitation Market: Collaborative Efforts by Hinge Health Inc., Doctor on …
Market Overview: The global telerehabilitation market size is poised to rise remarkably in the coming years attributable to the technological advancements in the field of healthcare services in collaboration with information, technology, and communications. Telerehabilitation is a medical service for people preferring to stay at home and avail treatment and services. As per a recent report by Fortune Business Insights, titled, "Telerehabilitation Market Size, Share and Industry Analysis By Type (Products,
Coronary Stents Market 2020 Trends, Market Share, Industry Size, Opportunities, …
Market Overview: The global coronary stents market size is projected to reach USD 8.08 billion by the end of 2027. High investment in technological intervention has opened up a huge potential for market growth. According to a report published by Fortune Business Insights, titled "Coronary Stents Market Size, Share and Global Trend by Deployment (Self and Balloon-expandable), Stent Type (Drug Eluting Stent, Bioresorbable Stent, Bare Metal Stent, Covered Stent and Others),

All 5 Releases

More Releases for Autotransfusion

Autotransfusion Services Market Companies to Watch Post-COVID
U.S. Autotransfusion Services Market Size | 2022 Covid-19 Impact On Healthcare Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape, And Regional Forecast To 2028 is latest study published by Fortune Business InsightsThe "U.S. autotransfusion services Market Forecast is set to gain impetus from the increasing number of surgical procedures occurring in the country. It is, in turn, expected to surge the need for
Autotransfusion Systems Market Report Up to 2031
Visiongain has published a new report on Autotransfusion Systems Market Report to 2031. Profiles of Leading Autotransfusion Systems Market players, Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios. Autotransfusion Systems is widely used to provide autologous blood during surgical procedures. In this process autotransfusion systems allows the transfusion of the patient’s blood rather than using the banked allogenic blood. It is incredibly useful during the critical procedures such as
Global Autotransfusion Devices Market - Forecasts to 2026
The findings reviewed by GME stated that the Global Autotransfusion Devices Market will expand at a CAGR value of 5.5% to reach USD 520 million by 2026 from USD 400 million in 2021. The rising cases of chronic diseases across the developing regions, increasing number of surgical procedures, and increasing number of liver or other organ transplant procedures are some of the key factors expected to drive market growth during
Autotransfusion Systems Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Autotransfusion Systems Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Autotransfusion Systems players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Autotransfusion Systems with respect to individual growth
Autotransfusion Devices Market: Increasing Use of Autotransfusion Devices in Hos …
Advancements in medical science have led manufacturers to develop various devices and medical equipment, human life betterment being the sole purpose. Such is the case with blood transfusion, where manufacturers have come up with devices that allow efficient and infection free transfusion. Autotransfusion devices are gaining high acceptance owing to benefits such as infection transmission, better transfer of oxygen and absence of isosensitization. Read Report Overview @ With increasing occurrence
Autotransfusion Devices Market This report studies Autotransfusion Devices in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Advancis Surgical Fresenius Kabi Haemonetics LivaNova Medtronic Terumo Corporation Atrium Medical Stryker ... On the basis of product, this report displays the production, revenue,